INVESTIGADORES
MORON Victor Gabriel
congresos y reuniones científicas
Título:
THE CHEMOKINE RECEPTOR CXCR4 MEDIATES NEUTROPHIL MIGRATION TO LYMPH NODES FROM BOTH BLOOD AND LYMPHATIC ROUTES
Autor/es:
CAROLINA GORLINO; SOFÍA CASTELLS; FLORENCIA HARMAN; ROMINA P. RANOCCHIA; GABRIEL MORÓN; BELKYS A. MALETTO; MARÍA C PISTORESI- PALENCIA.
Lugar:
Los Cocos
Reunión:
Congreso; LXI Reunión Anual de la Sociedad Argentina de Inmunología; 2013
Institución organizadora:
Sociedad Argentina de Inmunología
Resumen:
Although
much is described about the molecules involved in neutrophil migration from the
circulation into tissues, less is known about the molecular mechanisms that
regulate neutrophil entry into lymph nodes draining a local inflammatory site
(dLN). The aim of this study was to determine if chemokine receptors are
involved in neutrophil migration to dLN in a context of inflammation induced by
immunization of BALB/c mice with ovalbumin (OVA) emulsified in Complete
Freund?s Adjuvant (CFA). By confocal and flow cytometry analysis, we showed
that neutrophils can enter dLN of OVA/CFA mice via lymphatic vessels and also
from blood, across high endothelial venules. Additionally, we found that
neutrophil migration to dLN could be abrogated by pertussis toxin treatment
(p<0.001), demonstrating an involvement of G protein-coupled receptor
signaling in this influx. Next, we sought to define which chemokine receptor
could be implicated. ELISA assays of dLN homogenates showed that OVA challenge
triggered the modulation of the expression of multiple chemokines in OVA/CFA
mice (p<0.05). When we studied the expression of their specific receptors by
flow cytometry, cell-surface analysis revealed that CXCR4 was the only
chemokine receptor significantly up-regulated on blood neutrophils from OVA/CFA
mice (p<0.01). Moreover, CXCR4 was also found in most of dLN-infiltrating
neutrophils and also in those infiltrating the inflammatory site (p<0.05).
To specifically demonstrate the role of CXCR4 in neutrophil migration to dLN,
we performed adoptive transfer experiments to OVA/CFA mice which were treated
with the CXCR4 inhibitor, AMD3100. Neutrophils displayed diminished migration
to dLN from the inflammatory site and also from blood of AMD3100-treated mice
(p<0.05). Taken together, these results identify CXCR4 as a chemokine
receptor involved in the migration of neutrophils to dLN via blood and lymph.